Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,62 CAD | +0,28% | -8,35% | -8,35% |
Omzet 2024 * | 63,87 mln. 86,71 mln. 59,17 mln. | Omzet 2025 * | 73,45 mln. 99,72 mln. 68,05 mln. | Marktkapitalisatie | 85,03 mln. 115 mln. 78,78 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -20 mln. -27,15 mln. -18,53 mln. | Nettowinst (verlies) 2025 * | -17 mln. -23,08 mln. -15,75 mln. | EV/omzet 2024 * | 1,33 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,16 x |
K/w-verhouding 2024 * |
-4,19
x | K/w-verhouding 2025 * |
-4,84
x | Werknemers | 91 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,51% |
Recentste transcriptie over HLS Therapeutics Inc.
1 dag | +0,28% | ||
1 week | -8,35% | ||
Lopende maand | -13,40% | ||
1 maand | -9,05% | ||
3 maanden | -0,82% | ||
6 maanden | -29,71% | ||
Lopend jaar | -8,35% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Craig Millian
CEO | Chief Executive Officer | 56 | 01-05-23 |
John Hanna
DFI | Director of Finance/CFO | - | 22-06-23 |
Ryan Lennox
CMP | Compliance Officer | 43 | 07-05-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Welborn
CHM | Chairman | 46 | 18-06-21 |
Laura Brege
BRD | Director/Board Member | 66 | 21-03-19 |
John Hanna
DFI | Director of Finance/CFO | - | 22-06-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 3,62 | +0,28% | 1 300 |
26-03-24 | 3,61 | -1,90% | 132 900 |
25-03-24 | 3,68 | -4,17% | 9 475 |
22-03-24 | 3,84 | -2,78% | 38 340 |
21-03-24 | 3,95 | 0,00% | 24 901 |
uitgestelde koers Toronto S.E., 27 maart 2024 om 18:58 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,35% | 85,03 mln. | |
+16,48% | 70,86 mld. | |
+11,65% | 27,37 mld. | |
-1,96% | 8,14 mld. | |
+1,91% | 7,92 mld. | |
-25,23% | 7,51 mld. | |
+1,40% | 4,65 mld. | |
+10,56% | 4,08 mld. | |
+3,02% | 4,12 mld. | |
-4,65% | 3,92 mld. |